Background: Enhanced cyclooxygenase-2 (COX-2) expression is associated with carcinogenesis, ischemia, angiogenesis, inflammation, and neurodegeneration. The preventing effect of aspirin and nonsteroidal anti-inflammatory drugs is partly due to inhibition of the COX-2 enzyme. Fruit and vegetables (FVs) contain numerous compounds that may decrease disease risk by several different mechanisms, for example through the inhibition of COX-2 activity. Objective: We tested the hypothesis that an increased intake of FVs would modulate the COX-2 expression in peripheral blood cells. Design: A strictly controlled dietary crossover study (n ¼ 39). After 1 week run-in period with no FVs in the diet, one group was given two portions of FVs (2 FV), while another group was given five portions (5 FV) daily for 14 days. Following a 2 weeks washout period and 1 week run-in, the regimens were switched between the groups. Gene expression analysis of COX-2 mRNA in blood samples was performed by quantitative real-time-PCR. Results: No significant treatment effect of diet intervention was found in the crossover analyses (P ¼ 0.74). However, the individual variation in response may seem large. Conclusions: These data does not contradict the recommendations for an increased intake of FVs. Further studies on expression directly and indirectly, through analysis of factors regulating and being regulated by COX-2, should be carried out. A first step would be to evaluate the correspondence between COX-2 mRNA expression and products of the COX pathway, like prostaglandins. Naturally occurring polymorphisms of COX-2 promoters and coding regions might contribute to functional variations and response to different diets.
Introduction
Enhanced cyclooxygenase-2 (COX-2) expression is associated with several physiologic and pathologic processes, including colon carcinogenesis, ischemia, angiogenesis, inflammation, and neurodegeneration. Aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) have been found to help prevent these diseases (Jack, 1997; DuBois, 2003; Vane, 2003; Wu et al, 2003) . The underlying mechanism of these drugs may partly be due to inhibition of COX-2 activity (Vane, 2003) . COX-2 is one of the rate-limiting enzymes in the metabolism of arachidonic acid (AA) to a series of products such as prostaglandins (PGs) and other eicosanoids (DuBois, 2003; Wu et al, 2003) . The AA metabolites play a critical role in various physiological and pathophysical processes.
It has been estimated that in the Netherlands a 6-28% reduction in cancer incidence and a 6-22% reduction in cardiovascular deaths could be achieved by increasing the intake of fruits and vegetables (FVs) from the current 250 g/ day to the Dutch recommended 400 g/day among the Dutch population (van't Veer et al, 2000) . In Norway, it has been calculated that a 65% increase of the intake of FVs will reduce the incidence of cancer by about 23% or about 4000 cases every year (Blomhoff, 1998) . FVs contain multiple agents (vitamins, minerals, antioxidants, fiber, isothiocyanates, resveratrol, organosulfur compounds, terpenes, etc) that may decrease disease risk by several types of mechanisms (Wargovich et al, 2001; Kim et al, 2002; Lampe, 2003; Li et al, 2003; Little et al, 2003; Manson, 2003) . FVs, berries, herbs and spices are also sources of naturally occurring salicylates (Swain et al, 1984; Janssen et al, 1996; Venema et al, 1996; . The uses of preparations of certain plants and herbs to treat inflammatory conditions goes back several thousand years (Jack, 1997; Wargovich et al, 2001; Li et al, 2003) . Dietary salicylic acid appears to inhibit the transcription of the COX gene and inhibition occurs at concentrations found among those taking low doses of aspirin and vegetarians (Xu et al, 1999; Blacklock et al, 2001) . It is thus of interest to see if commercially available FVs affects COX-2 expression in humans.
The aim of the present study was to investigate if increased intake of mixed FVs would influence the expression of COX-2 mRNA in human peripheral blood cells, in attempt to further justify recommendations for increased intake of FVs. Blood cells were selected because peripheral blood monocytes are found highly inducible (Hla & Neilson, 1992) . In highly inducible cells it would thus be more likely to detect smaller changes in expression.
Methods

Study design and subjects
The design and the data for this strictly controlled dietary crossover study were derived from students participating in a study on biomarkers for intake of antioxidants. The design has been described in details recently (Brevik et al, 2004a, b) . Participants were stratified on the basis of gender and randomised into separate groups, group A and B, respectively. Group A was assigned to a diet containing 300 g mixed FVs (2 FV) in the first diet period, lasting for 14 days, while the diet of group B during the same period contained 750 g (5 FV). The groups switched to 5 FV and 2 FV, respectively, in the second 14 days term. The two diet periods were separated by a washout period of 14 days. During washout, the participants consumed a normal diet. Before each diet period, all participants had to go through a 7 days run-in period on a self-selected diet omitting FVs. The run-in periods were included to establish a common starting point as far as this was possible. Thus, the overall study design was 1 week (run-in) þ 2 weeks (baseline 1Àdiet period 1) þ 2 weeks (washout) þ 1 week (run-in) þ 2 weeks (baseline 2Àdiet period 2).
Participants were recruited among students from the Medical faculty, University of Oslo, Norway. Inclusion criteria among the selected students were a body mass index (BMI) r30 kg/m 2 , alcohol consumption r30 g/day, no use of vitamins or other food supplements the previous 2 months, age r35 y, no allergies, no prescribed medication (except contraceptives), no smoking and no major fluctuations in body weight (o2 kg) during the last 2 y before baseline. BMI was calculated as weight (kg) divided by the height in squared meters (m 2 ).
Diets
The composition of the diets is described in details elsewhere (Brevik et al, 2004a, b) . They were chosen to match a typical Norwegian diet. The diet with two daily portions of FVs contained a total of 300 g mixed FVs (2 FV) and the diet with five daily portions contained 750 g (5 FV). The FVs included are used in the habitual Norwegian diet (raspberry, blueberry, red pepper, pear, tomatoes, jam, apple, orange, onion, broccoli, cauliflower, orange juice and carrot). All FVs were from the same batch, and the servings were preprepared before the intervention and frozen at À201C. Prior to serving, vegetables were slightly heated. The relative amounts of different FVs were the same in both 2 FV and 5 FV. No spices or herbs were added to the diets. All subjects had diets with energy levels related to their energy needs (isoenergic diets). The relative content of energy from protein, fat and carbohydrates was similar for all energy levels. Dinner and all the included FVs were served and eaten under supervision of researchers at the Institute for Nutrition Research. Participants were free to choose the location for intake of meals other than dinners, but the consumption and composition was according to specific instructions, and consisted of standardized meals based on bread. Energy intake was adjusted through breakfast, lunch and snack meals. Except for a small amount of jam, these meals were all deprived of FVs. All food items eaten in the two FV diet periods were supplied except for milk and spreads, which the participants were allowed to choose on a daily basis from a few alternatives. No additional foods were allowed. On weekends all foods were supplied frozen in thermobags.
Energy requirements were calculated on the basis of basal metabolic rate (BMR) and patterns of physical activity obtained from a personal interview (Almendingen et al, 1998) . BMR was calculated using standard formulas FAO. During the diet periods, all subjects were weighed 3 times weekly. Dietary intake of total energy from fat, protein and carbohydrates in the diet were calculated using a newly developed software tool (KBS, version 3.1, 2002) linked to the national food composition table. All unconsumed food items were subtracted and data from the subjects actual consumption were used for calculation of total energy intake.
RNA isolation and real-time reverse transcriptasepolymerase chain reaction (RT-PCR)
Fasting blood samples were drawn between 0700 and 0930 on day 1 and 14 in each of the respective intervention periods. Consequently, a total of four samples from each individual were obtained. Before the trial, each subject was assigned a number used for labelling. In this way, the laboratory staff was kept unaware of the subject's diet sequence.
RNA was extracted from 150 ml fresh blood using the Total RNA Chemistry (Applied Biosystems) for whole blood. The isolations were performed on the ABI Prism 6700t Automated Nucleic Acid Workstation. Protocols were according to the manufacturer's recommendation. cDNA was synthesized from approximately 1 mg total RNA using the High Capacity cDNA Archive kit (Applied Biosystems). Primers and probe for the COX-2 assay were as follows: Quantitative RT-PCR Gene expression based on mRNA analysis of COX-2 was performed by quantitative RT-PCR on ABI prism 7900HT sequence detector (Applied Biosystems). The principle of mRNA-based gene expression analysis is reviewed by Bustin (2002) . Gene expression of GAPDH was used for normalization, and the relative quantitation of COX-2 gene expression was performed using the standard curve method (http://docs.appliedbiosystems.com/pebiodocs/ 04303859.pdf:User bulletin #2; Relative quantitation of gene expression). The PCR was carried out with the Platinum s Quantitative PCR Supermix-UDG kit (Invitrogen) using 5 ml cDNA, corresponding to 25 ng total RNA in a 25 ml final volume, 0.5 ml ROX (Invitrogen) 6 mM MgCl, 300 mM of each primer and 200 mM probe. The reaction conditions were initiated by a step of 2 min at 501C and 2 min of initial denaturation at 951C, followed by 50 cycles of denaturation at 951C for 15 s and annealing at 601C for 1 min. The plasmid standard curve and a nontemplate control were included in each experiment. Plasmid standards and samples were analyzed in triplicates for both the COX-2 and the GAPDH assays. The average of the three COX-2 values was divided by the average of the corresponding GAPDH values, generating a normalized value of COX-2 expression, which is a unitless number used to compare the relative amount of COX-2 mRNA in the different samples. The intra-/inter-assay precision, defined as the coefficient of variation (CV) for the COX-2 and GAPDH quantitative RT-PCR assays was o1.16/o0.94% and o1.23/o0.96%, respectively. The intraassay calculations were based on the Ct variation from the Ct mean value of the triplicates of each cDNA-sample in this study. The inter-assay calculations were based on the plasmid standards included in each experiment. The coefficient of variation based on the 39 individual levels obtained at baseline 1 was 54%.
Statistical analyses
Since the response data were skewed, we log transformed these data to obtain normality in the crossover analysis (Altmann, 1991) . The untransformed values are, however, presented in text, tables and figures. The analyses of a two-treatment crossover study can be presented as three twosample t-tests. Before comparing the treatments, the possibility of a period effect and a period-treatment interaction effect (carryover effect) were tested. A potential period effect was tested by a two-sample t-test to compare differences between the diet periods in the two groups of participants. The t-test for period effect is thus a two-sample t-test comparing differences between 2 FV and 5 FV in group A with differences between 2 FV and 5 FV in group B. Possible treatment-period interaction was investigated by noticing that in the absence of an interaction a subject's average response to the two diets should be similar regardless of the order in which the diets were given. The test for interaction is thus a two-sample t-test comparing average for group A with average for group B. Since the two crossover groups were not the same size, the effect of the experimental diet was tested by performing a two-sample t-test to compare the average differences between the two treatments. Results are presented as mean values together with standard error of the mean (s.e.m.). Significance level was set to 5%, and all analyses were performed using SPSS 11.
Results
A total of 39 participants (19 males and 20 females) remained fixed to the designed diet regiments. Age of participants ranged from 19 to 34 y (mean 23 y). BMI ranged from 18.3 to 27.8 kg/m 2 (mean 22 kg/m 2 ). The dietary compliance was very high. All experimental FVs were consumed, except for one portion of 123 g of fruit salad forgotten by one subject in the first diet period. For the rest, no lack of compliance was Modulation of COX-2 expression K Almendingen et al reported. Uses of NSAIDs were asked for, but no participants had used any NSAIDs. The initial fasting weights were not significantly different from the fasting weights after completion of the study. There were no differences in the measured baseline values between group A and B (Brevik et al, 2004a, b) .
Levels of COX-2 expression at different stages of the intervention are shown in Table 1 . In the crossover analysis no treatment effect was found (P ¼ 0.74) ( Table 2) . Moreover, no period or period-treatment effect was found.
The individual variation in response to the two diets may seem large. Baseline 1 represents the expression levels at first blood sampling and 5 FV the levels at the diet with the highest exposure to FVs ('5 a day'). When looking at the absolute differences between baseline 1 and 5 FV, nine subjects (23%) had a difference within 70.010, which may be defined as a very small difference. This value (0.010) is corresponding to the s.e.m. values for most of the comparisons shown in Table 1 . Of the rest, 14 subjects (36%) had higher levels and 16 subjects (41%) had lower levels at 5 FV. In 17 students (44%), the absolute expression levels were reduced on both test diets as compared to the levels at baseline 1. In opposite, in 12 students (31%) the levels were increased on the test diets as compared to baseline 1. The difference in COX-2 expression between the 2 FV and the 5 FV diet periods was within 70.010 for five students (13%). The standard deviation for the difference between 2 FV and 5 FV was 0.064. It was 29 students (74%) who had a difference between 2 FV and 5 FV that was within 70.064. Of the rest, five students (13%) had a positive difference and five students (13%) had a negative difference between 2 FV and 5 FV.
Discussion
The major finding from this strictly controlled crossover study was that no significant effect of diet intervention on COX-2 expression in peripheral blood cells was found in the crossover analyses. The absolute expression levels were, however, nonsignificantly reduced on both diets as compared to the levels at baseline 1 (no FVs) in 44% of the students. To our knowledge, this is the first dietary controlled study measuring the levels of COX-2 expression in human fresh blood cells.
Knowledge on how cells respond in vivo is limited. No paper known to the authors is published on COX-2 expression in peripheral blood cells in vivo. A quercetin metabolite-rich diet was not enough to change the COX-2 expression in human lymphocytes even if this was anticipated from ex vivo experiments (de Pascual-Teresa et al, 2004) . This later result indicate that ex vivo experiments do not necessary model an in vivo environment. Leukocytes grown in culture media responded markedly different than cells grown in blood plasma, which is believed to be more authentic to an in vivo environment (Angelis-Stoforidis et al, 1998) . Studies in vitro and ex vivo have shown that the COX-2 level in lymphocytes, neutrophils and monocytes are found inducible (Kimura et al, 2003; Capone et al, 2004; de PascualTeresa et al, 2004) .
Our study supported that COX-2 analyses may be performed directly on total RNA from peripheral blood cells (Warner et al, 1999; Plummer et al, 2001; Goppelt-Struebe et al, 2003) . It remains unclear why some individuals seem to be largely unaffected, and why some even had an increased expression of COX-2 on the diets. One could speculate on a heterogenous response to the diets. Information is, however, lacking considering the individual natural variation concerning COX-2 expression in blood cells. We do not know if the measured differences are of clinical significance. Further studies on expression directly and indirectly, through analysis of factors regulating and being regulated by COX-2, should, however, be carried out. A first step would be to evaluate the correspondence between COX-2 mRNA expression and products of the COX pathway, like prostaglandins. Naturally occurring polymorphisms of COX-2 promoters and coding regions might contribute to functional variations and response to different diets. To our knowledge, few studies addressing the question of functional consequences of COX-2 gene polymorphisms have been carried out. This might be due to the fact that only a few polymorphisms have been reported and these are not located in any known transcription binding site with the potential to affect the transcription of COX-2 (Humar et al, 2000; Fritsche et al, 2001) . However, Papafili et al (2002) identified a new COX-2 promoter variant, which is located within a putative binding site for Sp1. The described variant À765G4C has a 30% lower promoter activity compared with the À765G allele. In future studies, it would be of interest to evaluate this particular polymorphism in conjunction with the COX-2 mRNA expression. Such studies should be performed in heterogenous populations. Even if some correspondence is detected between COX-2 variant, response of the FV diets and mRNA expression, these questions needs further elucidation.
In addition to antioxidants, fiber, etc the 5 FV diet also provided the highest intake of several types of compounds that may decrease disease risk by several types of mechanisms. For several reasons, it was not possible to analyze the variety of naturally occurring potential chemopreventive compounds in the two test diets. We, however, estimated the content of dietary salicylates based on data obtained from three different publications (Swain et al, 1984; Janssen et al, 1996; Venema et al, 1996) . We found that all the different types of FVs provided in total less than 5-10 mg/day on the 5 FV diet. This intake might be too low to affect the expression of COX-2 in peripheral blood cells. We notably did not include herbs and plant extracts that are especially rich in dietary salicylates. Depending on the diet composition, a vegetarian diet will provide a much higher intake of both dietary salicylates and other potential beneficial compounds than the present test diets did. One relevant study found that curcumin (isolated from the spice tumeric) inhibits leukocyte COX-2 gene induction and concomitant PGE 2 production when added to human blood in vitro (Plummer et al, 2001) . However, since tumeric is not normally used in the Norwegian diet, this spice was not added to the present diets. Two portions of FVs per day was chosen because this corresponds to the average intake in several industrialized countries like Norway, Sweden, Denmark, The Netherlands, Germany, United Kingdom, Spain, Greece and Italy (Agudo et al, 2002) . The diet with '5 a day' was chosen because it corresponds to the recommendations. The FVs are all used in a traditional Norwegian diet. The effects of a diet with an even higher intake of the same FVs, or of a diet with another mix of FVs, including herbs and spices, can only be speculated upon. In any case, the present data do not contradict the current recommendations for an increased intake of FVs in general.
In a small clinical study, Aronson et al (2001) found that compared to the baseline expression, a 3-month intervention consisting of a low-fat diet, supplemented with fish oil, led to a decreased expression of prostatic tissue COX-2 in four of seven patients with pancreatic cancer. In general, long chained omega-3 fatty acids inhibit COX-mediated AA metabolism (Bagga et al, 2003; Dommels et al, 2003) . Fatty acids are able to regulate gene expression through peroxisome proliferator-activated receptors (PPARs) (Meade et al, 1999) . One potential mechanism is through the perioxisome proliferator response element (PPRE) element located in the regulatory region of COX-2 (Meade et al, 1999) . The present study was, however, balanced with respect to fat intake.
The present data represent the levels of relatively unstimulated COX-2 in peripheral blood cells in healthy young students. We cannot rule out that healthy students without any known inflammatory conditions may respond differently from individuals with neoplastic or inflammatory conditions. Moreover, since COX-2 expression is tissue dependent, results from peripheral blood cells might differ from cells in organ tissues. In future studies, it would thus also be of interest to compare the effects of different types of diets on the levels of COX-2 expression in both blood cells and in tissues.
The present design is regarded a gold standard in dietary research (Altmann, 1991) . Prior to the baseline, all students had eaten a run-in diet low in FVs. No type of dietary supplements was used 2 months ahead of baseline, nor during the intervention period. Since the compliance was very high, this design enables us to assume that observed effects are due to the differential intake of FVs. The students were, for obvious reasons, not blinded as to the sequence of their diet. However, it is highly unlikely that awareness of the nature of their diets could have affected the outcome in the presented study. We can, however, not exclude the presence of a type II error. When comparing the results from the present controlled study to a general free-living population, it is important to keep in mind all the other factors that may influence the expression of COX-2 in addition to the intake of FVs. In addition to a potential large interindividual variation due to genetic differences, it is possible that expression of COX-2 is affected by other dietary-related factors, and in particular fat intake and the use of NSAIDs.
In conclusion, no significant effect of diet intervention was found on COX-2 mRNA expression in peripheral blood cells among these healthy young individuals. The present data, though, do not contradict the current dietary recommendations for an increased intake of FVs.
